Adeno-associated virus vectors and hematology

Blood

Volumn 94, Issue 3, 1999, Pages 864-874

  Russell, David W ^a   Kay, Mark A ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CYTOKINE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; GENE CASSETTE; GENE EXPRESSION; GENE LOCUS; GENE THERAPY; HEMATOPOIETIC STEM CELL; HEMOPHILIA B; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME;

EID: 0033178657     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.864.415k34_864_874     Document Type: Review

References (130)

1. Muzyczka N: Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol 158:97, 1992
2. Atchison RW, Casto BC, Hammon WM: Adenovirus-associated defective virus particles. Science 149:754, 1965
3. Bantel Schaal U, zur Hausen H: Characterization of the DNA of a defective human parvovirus isolated from a genital site. Virology 134:52, 1984
4. Hoggan MD, Blacklow NR, Rowe WP: Studies of small DNA viruses found in various adenovirus preparations: Physical, biological, and immunological characteristics. Proc Natl Acad Sci USA 55:1467, 1966
5. Parks WP, Melnick JL, Rongey R, Mayor HD: Physical assay and growth cycle studies of a defective adeno-satellite virus. J Virol 1:171, 1967
6. Srivastava A, Lusby EW, Berns KI: Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol 45:555, 1983
7. Muramatsu S, Mizukami H, Young NS, Brown KE: Nucleotide sequencing and generation of an infectious clone of adeno-associated virus 3. Virology 221:208, 1996
8. Rutledge EA, Halbert CL, Russell DW: Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 72:309, 1998
9. Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM: Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 71:6823, 1997
10. Chiorini JA, Kim F, Yang L, Kotin RM: Cloning and characterization of adeno-associated virus type 5. J Virol 73:1309, 1999
11. Bantel-Schaal U, Delius H, Schmidt R, zur Hausen H: Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol 73:939, 1999
12. Blacklow NR, Hoggan MD, Kapikian AZ, Austin JB, Rowe WP: Epidemiology of adenovirus-associated virus infection in a nursery population. Am J Epidemiol 88:368, 1968
13. Georg Fries B, Biederlack S, Wolf J, zur Hausen H: Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 134:64, 1984
14. Parks WP, Boucher DW, Melnick JL, Taber LH, Yow MD: Seroepidemiological and ecological studies of the adenovirus-associated satellite viruses. Infect Immun 2:716, 1970
15. Blacklow NR, Hoggan MD, Rowe WP: Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst 40:319, 1968
16. Kotin RM, Menninger JC, Ward DC, Berns KI: Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831, 1991
17. Kotin RM, Siniscalco M, Samulski RJ, Zhu XD, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns KI: Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87:2211, 1990
18. Samulski RJ, Zhu X, Xiao X, Brook JD, Housman DE, Epstein N, Hunter LA: Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [published erratum appears in EMBO J 11:1228, 1992]. EMBO J 10:3941, 1991
19. Weitzman MD, Kyostio SR, Kotin RM, Owens RA: Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc Natl Acad Sci USA 91:5808, 1994
20. Giraud C, Winocour E, Berns KI: Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J Virol 69:6917, 1995
21. Linden RM, Winocour E, Berns KI: The recombination signals for adeno-associated virus site-specific integration. Proc Natl Acad Sci USA 93:7966, 1996
22. Balague C, Kalla M, Zhang WW: Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J Virol 71:3299, 1997
23. Surosky RT, Urabe M, Godwin SG, McQuiston SA, Kurtzman GJ, Ozawa K, Natsoulis G: Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J Virol 71:7951, 1997
24. Shelling AN, Smith MG: Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther 1:165, 1994
25. Pieroni L, Fipaldini C, Monciotti A, Cimini D, Sgura A, Fattori E, Epifano O, Cortese R, Palombo F, La Monica N: Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249:249, 1998
26. Palombo F, Monciotti A, Recchia A, Cortese R, Ciliberto G, La Monica N: Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J Virol 72:5025, 1998
27. Russell DW, Miller AD, Alexander IE: Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 91:8915, 1994
28. Kearns WG, Afione SA, Fulmer SB, Pang MC, Erikson D, Egan M, Landrum MJ, Flotte TR, Cutting GR: Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther 3:748, 1996
29. Rutledge EA, Russell DW: Adeno-associated virus vector integration junctions. J Virol 71:8429, 1997
30. Walsh CE, Liu JM, Xiao X, Young NS, Nienhuis AW, Samulski RJ: Regulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector. Proc Natl Acad Sci USA 89:7257, 1992
31. Yang CC, Xiao X, Zhu X, Ansardi DC, Epstein ND, Frey MR, Matera AG, Samulski RJ: Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J Virol 71:9231, 1997
32. Ponnazhagan S, Erikson D, Kearns WG, Zhou SZ, Nahreini P, Wang XS, Srivastava A: Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther 8:275, 1997
33. Xiao X, Li J, Samulski RJ: Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224, 1998
34. Allen JM, Debelak DJ, Reynolds TC, Miller AD: Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J Virol 71:6816, 1997
35. Gao GP, Qu G, Faust LZ, Engdahl RK, Xiao W, Hughes JV, Zoltick PW, Wilson JM: High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum Gene Ther 9:2353, 1998
36. Inoue N, Russell DW: Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. J Virol 72:7024, 1998
37. Fisher KJ, Gao GP, Weitzman MD, DeMatteo R, Burda JF, Wilson JM: Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 70:520, 1996
38. Ferrari FK, Samulski T, Shenk T, Samulski RJ: Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 70:3227, 1996
39. Alexander IE, Russell DW, Miller AD: Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results. Hum Gene Ther 8:1911, 1997
40. Mizukami H, Young NS, Brown KE: Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein. Virology 217:124, 1996
41. Summerford C, Samulski RJ: Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438, 1998
42. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A: Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 5:71, 1999
43. Summerford C, Bartlett JS, Samulski RJ: AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection. Nat Med 5:78, 1999
44. Bartlett JS, Samulski RJ, McCown TJ: Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 9:1181, 1998
45. Hermonat PL, Muzyczka N: Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81:6466, 1984
46. Lebkowski JS, McNally MM, Okarma TB, Lerch LB: Adeno-associated virus: A vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8:3988, 1988
47. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N: Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62:1963, 1988
48. Tratschin JD, Miller IL, Smith MG, Carter BJ: Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cells. Mol Cell Biol 5:3251, 1985
49. Handa H, Shiroki K, Shimojo H: Establishment and characterization of KB cell lines latently infected with adeno-associated virus type 1. Virology 82:84, 1977
50. Berns KI, Pinkerton TC, Thomas GF, Hoggan MD: Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68:556, 1975
51. Laughlin CA, Cardellichio CB, Coon HC: Latent infection of KB cells with adeno-associated virus type 2. J Virol 60:515, 1986
52. Fisher KJ, Jooss K, Alston J, Yang Y, Haecker SE, High K, Pathak R, Raper SE, Wilson JM: Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med 3:306, 1997
53. Clark KR, Sferra TJ, Johnson PR: Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum Gene Ther 8:659, 1997
54. Xiao X, Li J, Samulski RJ: Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70:8098, 1996
55. Miao C, Snyder R, Schowalter D, Patijn G, Donahue B, Winther B: The kinetics of rAAV integration in the liver. Nat Genet 19:13, 1998
56. Bertran J, Miller JL, Yang Y, Fenimore Justman A, Rueda F, Vanin EF, Nienhuis AW: Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol 70:6759, 1996
57. Malik P, McQuiston SA, Yu XJ, Pepper KA, Krall WJ, Podsakoff GM, Kurtzman GJ, Kohn DB: Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol 71:1776, 1997
58. Russell DW, Hirata RK: Human gene targeting by viral vectors. Nat Genet 18:325, 1998
59. Alexander IE, Russell DW, Miller AD: DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68:8282, 1994
60. Russell DW, Alexander IE, Miller AD: DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 92:5719, 1995
61. Qing K, Khuntirat B, Mah C, Kube DM, Wang XS, Ponnazhagan S, Zhou S, Dwarki VJ, Yoder MC, Srivastava A: Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J Virol 72:1593, 1998
62. Qing K, Wang XS, Kube DM, Ponnazhagan S, Bajpai A, Srivastava A: Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci USA 94:10879, 1997
63. Chen WY, Bailey EC, McCune SL, Dong JY, Townes TM: Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA 94:5798, 1997
64. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ: Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90:10613, 1993
65. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ: Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148, 1994
66. Alexander IE, Russell DW, Spence AM, Miller AD: Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum Gene Ther 7:841, 1996
67. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ: Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93:14082, 1996
68. Koeberl DD, Alexander IE, Halbert CL, Russell DW, Miller AD: Persistent expression of human factor IX from mouse liver after intravenous injection of AAV vectors. Proc Natl Acad Sci USA 94:1426, 1997
69. Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD: Transduction by adeno-associated virus vectors in the rabbit airway: Efficiency, persistence, and readministration. J Virol 71:5932, 1997
70. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA: Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270, 1997
71. Mandel RJ, Spratt SK, Snyder RO, Leff SE: Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci USA 94:14083, 1997
72. Herzog RW, Hagstrom JN, Kung SH, Tai SJ, Wilson JM, Fisher KJ, High KA: Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sic USA 94:5804, 1997
73. Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW: Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:6916, 1997
74. Snyder RO, Spratt SK, Lagarde C, Bohl D, Kaspar B, Sloan B, Cohen LK, Danos O: Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum Gene Ther 8:1891, 1997
75. Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ: Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther 4:16, 1997
76. Duan D, Sharma P, Yang J, Yue Y, Dudus L, Zhang Y, Fisher KJ, Engelhardt JF: Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72:8568, 1998
77. Song S, Morgan M, Ellis T, Poirier A, Chesnut K, Wang J, Brantly M, Muzyczka N, Byrne BJ, Atkinson M, Flotte TR: Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 95:14384, 1998
78. Afione SA, Conrad CK, Kearns WG, Chunduru S, Adams R, Reynolds TC, Guggino WB, Cutting GR, Carter BJ, Flotte TR: In vivo model of adeno-associated virus vector persistence and rescue. J Virol 70:3235, 1996
79. Miller JL, Walsh CE, Ney PA, Samulski RJ, Nienhuis AW: Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: The effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer [published erratum appears in Blood 85:862, 1995]. Blood 82:1900, 1993
80. Einerhand MP, Antoniou M, Zolotukhin S, Muzyczka N, Berns KI, Grosveld F, Valerio D: Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther 2:336, 1995
81. Zhou SZ, Li Q, Stamatoyannopoulos G, Srivastava A: Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human beta-globin gene. Gene Ther 3:223, 1996
82. Hargrove PW, Vanin EF, Kurtzman GJ, Nienhuis AW: High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3′ gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89:2167, 1997
83. LaFace D, Hermonat P, Wakeland E, Peck A: Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162:483, 1988
84. Zhou SZ, Broxmeyer HE, Cooper S, Harrington MA, Srivastava A: Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol 21:928, 1993
85. Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE: Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179:1867, 1994
86. Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW: Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells [published erratum appears in Blood 85:862, 1995]. Blood 84:1492, 1994
87. Miller JL, Donahue RE, Sellers SE, Samulski RJ, Young NS, Nienhuis AW: Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells [published erratum appears in Proc Natl Acad Sci USA 92:646, 1995]. Proc Natl Acad Sci USA 91:10183, 1994
88. Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM: Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector [see comments]. J Clin Invest 94:1440, 1994
89. Luhovy M, McCune S, Dong JY, Prchal JF, Townes TM, Prchal JT: Stable transduction of recombinant adeno-associated virus into hematopoietic stem cells from normal and sickle cell patients. Biol Blood Marrow Transplant 2:24, 1996
90. + human hematopoietic progenitor cells after transduction. Blood 88:492, 1996
91. Ponnazhagan S, Yoder MC, Srivastava A: Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo. J Virol 71:3098, 1997
92. Ponnazhagan S, Mukherjee P, Yoder MC, Wang XS, Zhou SZ, Kaplan J, Wadsworth S, Srivastava A: Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 190:203, 1997
93. Schimmenti S, Boesen J, Claassen EA, Valerio D, Einerhand MP: Long-term genetic modification of rhesus monkey hematopoietic cells following transplantation of adenoassociated virus vector-transduced CD34+ cells. Hum Gene Ther 9:2727, 1998
94. Ponnazhagan S, Mukherjee P, Wang XS, Qing K, Kube DM, Mah C, Kurpad C, Yoder MC, Srour EF, Srivastava A: Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation. J Virol 71:8262, 1997
95. Wang L, Zoppe M, Hackeng T, Griffin J, Lee K-F, Verma I: A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 94:11563, 1997
96. Lin H-F, Maeda N, Smithies O, Straight D, Stafford D: A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 90:3962, 1997
97. Bi L, Lawler A, Antonarakis S, High K, Gearhart J, Kazazian HH: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 10:119, 1995
98. Brinkhous KM, Sigman JL, Read MS, Stewart PF, McCarthy KP, Ga T, Leppanen SD, Rup BJ, Keith JCJ, Schaub RG: Recombinant human factor IX: Replacement therapy, prophylaxis, pharmacokinetics, and immunogenicity in canine hemophilia B. Blood 88:2603, 1996
99. Kingdon HS, Hassell TM: Hemophilic dog model for evaluating therapeutic effectiveness of plasma protein fractions. Blood 58:868, 1981
100. Nichols TC, Bellinger DA, Reddick RL, Smith SV, Koch GG, Davis K, Sigman J, Brinkhous KM, Griggs TR, Read MS: The roles of von Willebrand factor and factor VIII in arterial thrombosis: Studies in canine von Willebrand disease and hemophilia A. Blood 81:2644, 1993
101. Herzog R, High K: Problems and prospects in gene therapy for hemophilia. Curr Opin Hemotol 5:321, 1998
102. Zatloukal K, Cotten M, Berger M, Schmidt W, Wagner E, Bimstiel ML: In vivo production of human factor VIII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Proc Natl Acad Sci USA 91:5148, 1994
103. Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK: Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice. Proc Natl Acad Sci USA 92:1023, 1995
104. Nakai H, Herzog R, Hagstrom J, Walter J, Kung S-H, Yang E, Tai S, Iwaki Y, Kurtzman G, Fisher K, Colosi P, Couto L, High K: Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600, 1998
105. Kay MA, Li Q, Liu TJ, Leland F, Toman C, Finegold M, Woo SL: Hepatic gene therapy: Persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum Gen Ther 3:641, 1992
106. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE: Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 5:40, 1998
107. Herzog R, Yang E, Couto L, Hagstrom J, Elwell D, Fields P, Burton M, Bellinger D, Read M, Brinkhous K, Podsakoff G, Nichols T, Hurtzman G, High K: Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5:56, 1999
108. Snyder R, Miao C, Meuse L, Tubb J, Donahue B, Lin H, Stafford D, Patel S, Thompson A, Nichols T, Read M, Bellinger D, Brinkhous K, Kay M: Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 5:64, 1999
109. Connelly S, Andrews J, Gallo A, Kayda D, Qian J, Hoyer L, Kadan M, Gorziglia M, Trapnel B, McClelland A, Kaleko M: Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91:3273, 1998
110. Evans G, Morgan R: Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad Sci USA 95:5734, 1998
111. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLL: In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2353, 1994
112. Patijn G, Lieber A, Schowalter D, Schwall R, Kay M: Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice. Hepatology 28:707, 1998
113. Bosch A, McCray P, Walters K, Bodner M, Jolly D, Van Es H, Nakmura T, Matsumoto K, Davidson B: Effects of keratinocyte and hepatocyte growth factor in vivo: Implications for retrovirus-mediated gene transfer to liver. Hum Gene Ther 9:1747, 1998
114. Kafri T, Bloomer U, Peterson DA, Gage FH, Verma IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314, 1997
115. Takeuchi Y, Cosset FL, Lachmann PJ, Okada H, Weiss RA, Collins MK: Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 68:8001, 1994
116. Russell DW, Berger MS, Miller AD: The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines. Hum Gene Ther 6:635, 1995
117. Smith TA, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 5:397, 1993
118. Connelly S, Mount J, Mauser A, Gardner JM, Kaleko M, McClelland A, Lothrop CD: Complete short-term correction of canine hemophilia A by in vivo gene therapy. Blood 88:3846, 1996
119. Rung S-H, Hagstrom J, Cass D, Tai S, Lin H-F, Stafford D, High K: Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 91:784, 1998
120. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Kay MA: Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther 2:151, 1995
121. Lieber A, He CY, Kirillova I, Kay MA: Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J Virol 70:8944, 1996
122. Schiedner G, Morral N, Parks RJ, Wu Y, Koopmans SC, Langston C, Graham FL, Beaudet AL, Kochanek S: Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18:180, 1998
123. Le M, Okuyama T, Cai SR, Kennedy SC, Bowling WM, Flye MW, Ponder KP: Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood 89:1254, 1997
124. Cai SR, Kennedy SC, Bowling WM, Flye MW, Ponder KP: Therapeutic levels of human protein C in rats after retroviral vector-mediated hepatic gene therapy. J Clin Invest 101:2831, 1998
125. Zhou S, Murphy J, Escobedo J, Dwarki V: Adeno-associated virus-mediated delivery of erythropoietin leads to sustained elevation of hemotocrit in nonhuman primates. Gene Ther 5:665, 1998
126. Ye X, Rivera VM, Zoltick P, Cerasoli F, Schnell MA, Gao GP, Hughes JV, Gilman M, Wilson JM: Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283:88, 1999
127. Bohl D, Salvetti A, Moullier P, Heard JM: Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92:1512, 1998
128. Rendahl KG, Leff SE, Otten GR, Spratt SK, Bohl D, Van Roey M, Donahue BA, Cohen LK, Mandel RJ, Danos O, Snyder RO: Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nat Biotechnol 16:757, 1998
129. Shibata T, Akiyama N, Noda M, Sasai K, Hiraoka M: Ehancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythopoietin genes. Int J Radiat Oncol Biol Phys 42:913, 1998
130. Bunn HF, Gu J, Huang LE, Park JW, Zhu H: Erythropoietin: A model system for studying oxygen-dependent gene regulation. J Exp Biol 201:1197, 1998